無(wú)癥狀期人類(lèi)免疫缺陷病毒感染者外周血淋巴細(xì)胞計(jì)數(shù)與總淋巴細(xì)胞計(jì)數(shù)的相關(guān)性分析

金艷濤，郭會(huì)軍，蔣自強(qiáng)

1　對(duì)象與方法

2　結(jié)果

2.1人口學(xué)資料共納入98例病例資料，其中男69例(占70.4%)，女29例(占29.6%)；年齡19～63歲，平均(42±11)歲。感染原因：有償獻(xiàn)血56例(占57.1%)，輸血4例(占4.1%)，性傳播25例(占25.5%)，不詳13例(占13.2%)。職業(yè)以農(nóng)民為主56例(占57.1%)，中學(xué)及以下文化程度78例(占79.6%)。

圖淋巴細(xì)胞計(jì)數(shù)與TLC的相關(guān)性

TLC(×106個(gè)/L)靈敏度特異度陽(yáng)性預(yù)測(cè)值陰性預(yù)測(cè)值一致率<110034.7897.3380.0082.9582.65<120039.1396.0075.0083.7282.65<130043.4896.0076.9284.7183.67<140056.5292.0068.4287.3483.67<150060.8786.6758.3387.8480.61<160060.8782.6751.8587.3277.55<170069.5774.6745.7188.8973.47<180078.2670.6745.0091.3872.45

TLC(×106個(gè)/L)靈敏度特異度陽(yáng)性預(yù)測(cè)值陰性預(yù)測(cè)值一致率<150032.2087.1879.1745.9554.08<160035.5984.6277.7846.4855.10<170044.0776.9274.2947.6257.14<180050.8574.3675.0050.0060.20<190062.7169.2375.5155.1065.31<200066.1066.6775.0056.5266.33<210074.5853.8570.9758.3366.33<220076.2746.1568.1856.2564.29

TLC(×106個(gè)/L)靈敏度特異度陽(yáng)性預(yù)測(cè)值陰性預(yù)測(cè)值一致率<190054.0281.8295.9218.3757.14<200054.4781.8296.1519.5760.20<210067.8272.7395.1622.2268.37<220070.1154.5592.4218.7568.37<230077.0154.5593.0623.0874.49<240081.6136.3691.0320.0076.53<250087.3627.2790.4821.4380.61

3　討論

1Wang H，Nishanian P，F(xiàn)ahey JL.Characterization of immune suppression by a synthetic HIV gp41 peptide[J].Cell Immunol，1995，161(2)：236-243.

3中華醫(yī)學(xué)會(huì)感染病學(xué)分會(huì)艾滋病學(xué)組.艾滋病診療指南(2011版)[J].中華傳染病雜志，2011，29(10)：629-640.

4金艷濤，蔣自強(qiáng)，郭會(huì)軍，等.無(wú)癥狀期HIV感染者生存質(zhì)量評(píng)價(jià)[J].中國(guó)全科醫(yī)學(xué)，2012，15(12)：4040.

5范思遠(yuǎn)，弓孟春，楊瑩韻，等.早期抗逆轉(zhuǎn)錄病毒治療改善無(wú)癥狀HIV-1感染者預(yù)后[J].中華內(nèi)科雜志，2011，50(6)：526-528.

6World Health Organization.Antiretroviral therapy for HIV infection in adults and adolescents：recommendations for a public health approach (2010 version).2010:1-145.[2010-09-22].http://whqlibdoc.who.int/publications/2010/9789241599764-eng.pdf.

7張福杰，王健，王福生，等.國(guó)家免費(fèi)艾滋病抗病毒藥物治療手冊(cè)[M].北京:人民衛(wèi)生出版社,2012.

8Joint United Nations Programme on HIV/AIDS (UNAIDS).UNAIDS report on global AIDS epidemic[R].WHO Library Cataloguing-in-Publication Data,2010.

9Obirikorang C,Quaye L,Acheampong I.Total lymphocyte count as a surrogate marker for CD4count in resource-limited settings[J].BMC Infectious Diseases,2012,12:128.

10Stebbing J,Sawleshwarkar S,Michailidis C,et al.Assessment of the efficacy of total lymphocytecounts as predictors of AIDS defining infections in HIV-1 infected people[J].Postgrad Med J,2005,81(959):586-588.

11Daka D,Loha E.Relationship between total lymphocyte count (TLC) and CD4count among peoples living with HIV,Southern Ethiopia:a retrospective evaluation[J].AIDS Res Ther,2008(5):26.

14Wang Y,Liang S,Yu E,et al.Correlation analysis on total lymphocyte count and CD4count in HIV-infected patients:a retrospective evaluation[J].J Huazhong Univ Sci Technol Med Sci[J].2011,31(5):712-716.

15de Jong MA,Rudi Wisaksana,Hinta Meijerink，et al.Total lymphocyte count is a reliable surrogate marker for CD4cell counts after the first year of antiretroviral therapy:data from an indonesian cohort study[J].Tropical Medicine and International Health,2012,17(5):581-583.